Related Experiment Video
Updated: Apr 5, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future
Jesper Lindhardsen1, Søren Lund Kristensen2, Ole Ahlehoff3
1Department of Internal Medicine, Copenhagen University Hospital Slagelse, 4200, Slagelse, Denmark.
Insights
Patients with chronic inflammatory diseases (CID) face higher cardiovascular disease (CVD) risks. Research explores inflammation inhibition for CVD prevention and improved patient management strategies.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Chronic inflammatory diseases (CID) like rheumatoid arthritis, psoriasis, inflammatory bowel diseases, and systemic lupus erythematosus are linked to increased cardiovascular disease (CVD) risk.
- This association contributes to reduced life expectancy in affected patients, necessitating focused research and clinical attention.
Purpose of the Study:
- To review the evidence connecting CIDs and CVD.
- To discuss current cardiovascular risk management recommendations for patients with CID.
- To explore future research directions and potential interventions for CVD prevention in this population.
Main Methods:
- Literature review of existing studies on CID and CVD.
- Analysis of current cardiovascular risk management guidelines.
- Discussion of ongoing and planned clinical trials.
Main Results:
- A significant association exists between chronic inflammation and heightened CVD risk.
- Current management strategies require adaptation for CID patients.
- Inhibiting inflammation is a promising therapeutic avenue for CVD prevention.
Conclusions:
- There is a clear need for multidisciplinary approaches and specialized guidelines for CVD prevention in patients with CID.
- Targeting inflammation holds potential for improving cardiovascular outcomes in these individuals.
- Further research and clinical trials are crucial to refine prevention and treatment strategies.
Abstract:
An increased risk of cardiovascular disease (CVD) has been observed in a range of chronic inflammatory diseases (CID), including rheumatoid arthritis (RA), psoriasis, inflammatory bowel diseases (IBD), and systemic lupus erythematosus (SLE). The increased risk of CVDs and reduced life expectancy in these conditions has stimulated considerable research and started an ongoing discussion on the need for a multidisciplinary approach and dedicated guidelines on CVD prevention in these patients. In addition, the possibility of inhibiting inflammation as a means to preventing CVD in these patients has gained considerable interest in recent years. We briefly summarize the current level of evidence of the association between CIDs and CVD and cardiovascular risk management recommendations. Perspectives of ongoing and planned trials are discussed in consideration of potential ways to improve primary and secondary CVD prevention in patients with CID.
Related Concept Videos
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Myocarditis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis IV: Nursing Management
